 |
|
 |
Biotechnology |
|
|
Labeling and Linkage Agents for Immunoassays and Gene Probes
Publication Date April 2006
Publisher Business Communications Company
Product Type Report
Pages 184
ISBN Number not applicable
Product Code BCC033
|
|
|
Summary
The segment of the diagnostic industry using immunoassays and gene probes is relatively young and undergoing rapid changes spurred on by the rapid progress in biotechnology and medicine. This area is now experiencing major R&D initiatives, resulting in the development of the number of new products, and in improvement of sensitivities and performance of several existing products. This has a direct impact on the demand, consumption and future growth of the labeling and linking agents that go into products. There is therefore a need for an up to date, comprehensive global report on reagents that make up diagnostic tests.
Scope Of Study
This important report:
- Assesses technological developments and how they will impact the industry
- Identifies the driving forces for demand
- Makes available the most current and reliable information on consumption of probes and related chemicals in enzyme immunoassay
- Estimates the global supply and demand scenario broken down by applications and regions
- Assesses the growth rate in demand
- Projects demand and supply by applications and regions up to 2010
- Profiles major companies involved in this business and their market shares.
Report Highlights
- In vitro and in vivo diagnostics account for nearly 87% of a total market of more than US $8.0 billion. This market will show a steady annual growth of around 6.6% for the next five years.
- Immunoassay analysis for environmental contaminants is a promising development sector in the coming years. Though the market for probes in environmental testing is small, it is expected to grow at the rate of around 10.5% per year, due to the increasing scientific awareness, bioterrorism preparedness and funding.
- Fluorescent compounds have the largest share of the market, followed by chemiluminescent and radioactive compounds which have about the same market share. All types of materials will have fairly healthy growth over the next five years.
|
Content
- Introduction
- Objectives And Goal Of The Study
- Reasons For Doing The Study
- Scope Of The Study
- Targeted Audience
- Methodology
- Credentials Of Analysts
- Related BCC Reports
- BCC Online Services
- Disclaimer
- Summary
- Summary Table: Markets For Labels And Probes By Application Area, Through 2010 ($ Millions)
- Summary Figure: Markets For Labels And Probes By Application Area, 2003-2010 ($ Millions)
- Technology Overview
- Immunoassay Technology
- Qualitative And Quantitative Immunoassays
- Application Fields For Immunoassay Techniques
- Comparison Of Immunoassays With Conventional Methods
- High Sensitivity
- High Selectivity
- Speed
- Cost Factors
- Easier Cleanup Process
- Efficiency
- Some Drawbacks
- Advances In Immunoassay Technology
- Methods Of Immunoassays
- Immunoprecipitation
- Particle Immunoassays
- Radioimmunoassay (RIA)
- Immuno Radiometric Assays
- Immunonephelometry And Fluorescent Immunoassay (FIA)
- Immunonephelometry
- Fluorescent Immunoassay (FIA)
- Fluorescence Polarization (FP): Variation Of Fia
- Comparative Performance Between Eia And Fia
- Enzyme Immunoassay (EIA) / Enzyme Linked Immunosorbent Assays (ELISA)
- Chemiluminecent Assay (CLIA)
- Examples Of Other Immunoassays
- Immunoassay Techniques
- Monoclonal-Polyclonal (Moab-Poab) Sandwich Immunoassay
- Competitive Inhibition Immunoassay
- Antigen-Down Immunoassay
- Rapid Immunoassays
- Gene Probe Technology (Nucleic Acid Assays)
- Construction Of Probes
- Probe Labeling
- Nonradioactive Labeling Of Gene Probes
- Immunoassay-Dna Probe Hybrid Assays
- Detection In Foods
- Chip-Based Nucleic Acid Assay
- Reporter Technology
- Examples Of Technology Developments
- Detection Of Dna Hybridization With Impedance Amplifying Labels
- Quantitative Fluorescent Immunoassay Of Antibodies
- Colorimetric Polymerase Assay
- Development And Proliferation Of Radioimmunoassay Technology
- Historic Milestones In Technology Development
- Immunoassays
- Gene Probes
- Radioactive Compounds
- Overview Of Probes And Related Chemicals
- Radioactive Compounds
- Enzymes/Enzyme Substrates
- Fluorescein Compounds
- Chemiluminescence Compounds
- Gene Probes
- Immunoassay-Dna Probe Hybrid Assays
- Food Testing
- Examples Of Radioactive Compounds And Their Applications
- 99mtc
- Positron Emitters
- Hepatobiliary Imaging
- Reticuloendothelial System
- Experimental Agents
- Enzyme Probes
- A Capture Eia Is Designed To Detect A Specific Type Of Antibody, Such As Igg Or Igm.
- Fluorescence Compounds
- Chemiluminescent Compounds
- Markets For Probes By Application Sectors
- Global Market For Probes
- In Vitro Diagnostics
- Medical Labs
- Types Of Tests
- Hospital Testing
- Types Of Tests
- Doctors' Offices
- Home Testing
- Typical Tests
- Likely Future Trends In The Probes Markets For Ivd Sector
- In Vivo Diagnostics
- Cancer
- Ophthalmic
- Scanning
- Dental
- Blood Banks
- Food Testing
- Research Laboratories
- Forensic And Paternity Markets
- Forensics
- Types Of Tests
- Paternity
- Types Of Tests
- Environmental Testing
- Market For Probes-By Materials
- Fluorescent Compounds
- Requirements For Fluorescent Compounds
- Applications Of Fluorescence Immunoassay
- Features
- Nucleic Acid Labeling
- Protein Labeling
- Commonly Used Fluorocompounds
- Radioactive Compounds
- Chemiluminescent Compounds
- Applications Of Chemiluminescent Compounds
- Factors In Choosing A Detection Reaction
- Enzyme/Enzyme Substrate
- Gene Probes
- Regulations Affecting The Industry
- Regulations Affecting Radioactive Materials
- Nuclear Regulatory Commission (NRC) Regulations
- Present Rules And Regulations
- Safety Standards
- Medical Use Policy Statement
- Advisory Committee
- Regulations Relating To Storage Of Radio Isotopes
- Sink Disposal
- Exemption To Small Quantity Isotopes
- European Regulations On Waste Disposal
- Permits For The Import Of Medical Radioisotopes In Australia
- Global Healthcare And Industry Trends
- World Population And Disease Profile
- World Population And Growth Rate
- Disease Profile
- Key Determinants Of Health
- Patient Care
- Driving Factors Of Testing In Developing Countries
- Driving Factors In Developed Countries
- Constraints For Growth
- The Stakeholders
- Technology Factors
- Factors Influencing Growth
- Extent Of Utilization Of Ivd Procedures
- Growth In Consumption
- Pattern Of Use
- Half Life And Limited Availability In Some Countries
- Environmental Issues
- Options For Minimizing Radioactive Waste Disposal Problems
- Cost Issues
- Substitution For Radioisotopes
- Future For Radioactive Probes
- Future For Chemiluminescent Probes
- Future For Enzyme-Based Assays
- Future For Fluorescent Probes
- Future For Gene Probes
- Probes-Technology And Patents
- Fluorescent Compounds
- Electronic Array Detectors
- Assay Sensitivity And Tagging Methods
- Simultaneous Analysis Of Multiple Samples For Multiple Analytes
- Diffusion Immunoassay (DIA)
- Stopped-Flow Fluorescence Polarization Immunoassay
- The Use Of Fluorescence Polarization Assays For The Detection Of Infectious Diseases
- Tissue Auto Fluorescence
- Chemiluminescent Compounds
- Assay Sensitivity And Tagging Methods
- Bioluminescent Tags
- Ck-Mb Test
- Radioactive Compounds
- Diagnosis Of Infectious And Inflammatory Disease
- Radiolabeled Peptides For Diagnosis And Therapy
- Use Of Low Radiation Dose
- Enzymes/Enzyme Substrates
- Diagnosis Of Cerebral Aspergillosis
- Nucleic Acid Modifying Enzymes
- Diagnosis Of Renal Disorders
- The Diagnosis Of Trypanosomosis In Animals
- Diagnosis Of Ectopic Pregnancy
- Immunoassays
- Markers For Risk Study
- Development Of Monoclonal Antibodies
- Assay Sensitivity And Tagging Methods
- Molecular Biology Techniques
- Gene Probes
- Recent Developments In Nucleic Acid Hybridization
- Real-Time Polymerase Chain Reaction (PCR) Testing
- Time Resolved Fluorescent (TRF) Immunoassay Testing
- Diagnosis Of Myocardial Infarction
- Tools For Reagent Immobilization
- Beads
- Dots
- Paramagnetic Particles
- Tools For Sample Collection
- Matrices For Test Development
- Interferences In Immunoassays
- Demand For Early Risk And Disease Detection
- Machinery And Platforms
- Patent Analysis
- Description Of Some Representative Patents
- New Imaging Agent For Cns Disorders
- Fluorobutenyl Tropanes For Mapping Transporter Sites
- Halogenated Pyrroloisoquinolines For Mapping Serotonin Transporter Sites
- Detection Of Prostrate Cancer
- Diagnosis And Monitoring Of Prostate Cancer Patients By Measurement Of Serum
- Detection Of Neurological Diseases
- Method Of Detecting Axonally-Derived Protein Tau In Patients With Traumatic Cns Injury
- Method Of Analyzing Ataxia-Telangiectasia Protein
- Detection Of Transmissible Spongiform Encephalopathies (TSES)
- Simultaneous Generation Of Multiple Chemiluminescent Signals On Solid Supports
- Monoclonal Anti-Human Breast Cancer Antibodies
- Autonomous Ingestible Probe For Diagnosis And Therapy Of Gastrointestinal Lesions Using Fluorescent Molecules
- Biochip Devices For Genetic Analyses
- New Biochip Methods And Devices That Reduce The Cost And Complexity Of Performing Genetic Analyses.
- Profile Of Major Players
- Market Share Of Major Players
- Abbott Laboratories
- Highlights
- Product Range
- Activities
- Facilities
- Collaboration
- Amersham Biosciences, Usa
- Background Details
- Product Range
- Activity
- Facilities
- Research And Development
- Global Operations
- Bachem Ag
- Gmp Production Sites
- Manufacturing Capabilities
- Major Milestones For Bachem
- Associated Units
- Product Range
- Sera And Antibody Products
- Elisa Kits
- Research Reagents
- Custom Iodination 125i-Labelling
- Facilities
- Collaborations
- Biofx Laboratories
- Locations
- Product Range
- Microwell Substrate
- Membrane Substrate
- Microwell Elisa - Peroxidase Enzyme Systems
- Other Details
- New Chemiluminescent Product For Peroxidase Enzyme Systems
- Bio-Nucleonics Inc.
- Activities
- Collaboration And Alliance Partner
- Bio-Rad, Usa
- Biotium, Usa
- Product Range
- Fluorescent Calcium Indicators And Related Products
- Fluorescent Indicators (Chloride, Ph, Etc.)
- Chloride Indicators
- Ph Indicators
- Zinc Indicators
- Enzyme Indicator
- Activities
- Biovectra Dcl, Usa
- Biozyme Laboratories
- Carbomer Inc.
- Activities
- Product Range
- Fluorescent Reagents
- Fluorescent Glycans
- Diagnostic Chemicals Limited, Usa
- Product Range
- Activity
- Other Details
- L3k Technology
- Immunodiagnostics
- Dutch Diagnostics
- Hytest Ltd.
- Institute Of Isotope Co. Ltd., Hungary
- Activity
- Product Range
- Radionuclides
- Radiochemicals
- Facilities
- International Murex Technologies Corporation /
- Murex Diagnostics Corp.
- Manufacturing Plants
- Product Range
- Milestones
- Lumigen, Inc
- Mds Nordion
- Expertise
- Product Range
- Activity
- Facilities
- Collaboration
- Moravek Biochemicals, Usa
- Perkinelmer Life Science, Inc.
- Activity
- Product Range
- Fluorescein-12-Dutp
- Nen Brand Fluorescent Nucleotide Analogs
- Research Products International Corp., Usa
- Sigma Aldrich, Usa
- Activities
- Product Range
- Enzymes
- Fluorescent Labels
- Amine Derivatives
- Theratase, Plc
- Background Details
- Product Range
- Collaboration
- Toyobo Enzymes
- Vector Labs
- Zymed Laboratories, Inc., Usa
- List Of Figures
- Summary Table: Markets For Labels And Probes By Application Area, Through 2010 ($ Millions)
- Table 1 Immunoassays: Historical Timeline
- Table 2 Gene Probes: Historical Timeline
- Table 3 Radioactive Compounds: Historical Timeline
- Table 4 Commonly Used Radioactive Isotopes
- Table 5 Radionuclides For Diagnostic Imaging
- Table 6 Radionuclides: Positron Emitters
- Table 7 Use Of Radioactive Probes: Thyroid Imaging
- Table 8 Use Of Radioactive Probes: Autoradiography
- Table 9 Use Of Radioactive Probes: In Diagnosis And Therapy
- Table 10 Use Of Radioactive Probes: Radiocardiography
- Table 11 Use Of Radioactive Probes: Tumor Imaging
- Table 12 Use Of Radioactive Probes: Cancer Treatment
- Table 13 Use Of Radioactive Probes: Determination Of Blood Cell Survival Time
- Table 14 Use Of Radioactive Probes: Determination Of Circulation Red Cell Mass/Plasma Volume
- Table 15 Use Of Radioactive Probes: Determination Of Blood Flow
- Table 16 Use Of Radioactive Probes: Stomach Imaging
- Table 17 Use Of Radioactive Probes: Excretion Study
- Table 18 Use Of Radioactive Probes: Treatment Of Leukemias
- Table 19 Use Of Radioactive Probes: Study Of Gastrointestinal Protein Loss
- Table 20 Use Of Radioactive Probes: Scanning Lungs/Brain
- Table 21 Use Of Radioactive Probes: Myocardial Studies
- Table 22 Use Of Radioactive Probes: Heart Imaging
- Table 23 Use Of Radioactive Probes: Brain Imaging
- Table 24 Use Of Radioactive Probes: Brain Perfusion Imaging
- Table 25 Use Of Radioactive Probes: Bone Imaging
- Table 26 Use Of Radioactive Probes: Lung Imaging
- Table 27 Use Of Radioactive Probes: Renal Imaging
- Table 28 Use Of Radioactive Probes: Malignant And Inflammatory Regions
- Table 29 Commonly Used Type Of Eias
- Table 30 Commonly Used Enzymes In Eias
- Table 31 Applications Of Enzymes In Immunoassay
- Table 32 Commonly Used Fluorophores In Fia
- Table 33 Fluorophores And Their Applications
- Table 34 Commonly Used Chemiluminescent Compounds
- Table 35 Global Market For Probes In Immunoassays By Application Sectors, Through 2010 ($ Millions)
- Table 36 Global Market By Materials For Probes In Immunoassays, Through 2010 ($ Millions)
- Table 37 Regional Share Of The Market For Probes In Immunoassays, Through 2010 ($ Millions)
- Table 38 Global Market For Probes For In Vitro Diagnostics By Application Sectors, Through 2010 ($ Millions)
- Table 39 Global Market For Probes For In Vitro Diagnostics By Region, Through 2010 ($ Millions)
- Table 40 Global Market For Probes For In Vitro Diagnostics By Reagents, Through 2010 ($ Millions)
- Table 41 Global Market For Probes For In Vitro Diagnostics Medical Labs, Through 2010 ($ Millions)
- Table 42 Global Market For Probes For In Vitro Diagnostics Hospital Testing, Through 2010 ($ Millions)
- Table 43 Global Market For Probes For In Vitro Diagnostics Doctor's Office, Through 2010 ($ Millions)
- Table 44 Global Market For Probes For In Vitro Diagnostics Home Testing, Through 2010 ($ Millions)
- Table 45 Global Market For Probes For In Vivo Diagnostics, Through 2010 ($ Millions)
- Table 46 Global Market For Probes In The Dental Area, Through 2010 ($ Millions)
- Table 47 Global Market For Probes In Blood Banks, Through 2010 ($ Millions)
- Table 48 Global Market For Probes In Food Testing, Through 2010 ($ Millions)
- Table 49 Global Market For Probes In Research Laboratories, Through 2010 ($ Millions)
- Table 50 Market For Probes In Forensic And Paternity, Through 2010 ($ Millions)
- Table 51 Global Market For Probes In Forensic And Paternity, Through 2010 ($ Millions)
- Table 52 Market For Probes In Environmental Testing, Through 2010 ($ Millions)
- Table 53 Global Market For Probes In Environmental Testing, Through 2010 ($ Millions)
- Table 54 Applications Of Specific Fluorescent Compounds
- Table 55 Market For Fluorescent Compounds By Material Types, Through 2010 ($ Millions)
- Table 56 Markets Of Fluorescent Compounds By Application Sectors, Through 2010 ($ Millions)
- Table 57 Market For Radioactive Compounds By Material Types, Through 2010 ($ Millions)
- Table 58 Radiopharmaceuticals Currently Used
- Table 59 Markets For Radioactive Compounds By Application Sectors, Through 2010 ($ Millions)
- Table 60 Types Of Chemiluminescent Assay
- Table 61 Types Of Luminescent Reactions
- Table 62 Market For Chemiluminescent Compounds By Material Types, Through 2010 ($ Millions)
- Table 63 Applications Of Selected Chemiluminescent Compounds
- Table 64 Markets Of Chemiluminescent Compounds By Application Sectors, Through 2010 ($ Millions)
- Table 65 Market For Enzymes And Their Substrates By Type, Through 2010 ($ Millions)
- Table 66 Selected Enzyme Immunoassay Applications
- Table 67 Markets For Enzymes And Their Substrates By Application Sectors, Through 2010 ($ Millions)
- Table 68 Market For Gene Probes, Through 2010 ($ Millions)
- Table 69 Markets For Gene Probes By Application Sectors, Through 2010 ($ Millions)
- Table 70 Historical Timeline Of Regulations Affecting The Handling Of Radioisotopes In The U.S.
- Table 71 Highlights Of Developments In Nrc Regulations
- Table 72 Hospital Bed Statistics For Selected Countries, 2004
- Table 73 Developments In Radiolabeled Compounds
- Table 74 Patent Analysis For Selected Organizations
- Table 75 Market Share Of Major Players In Medical Diagnostics
- Table 76 Representative Assay Products Of Abbott
- Table 77 Some Important Collaboration Efforts At Abbott
- Table 78 Major Milestones For Bachem
- Table 79 Bachem Units
- Table 80 Bachem Collaborations
- Table 81 Product Range And Application Of Biovectra Dcl
- Table 82 Representative Products Of Hytest
- Table 83 Representative Products Of Lumigen
- Table 84 Representative Collaboration Efforts Of Mds
- Table 85 Milestones For Sigma Aldrich
- Table 86 Representative Products Of Toyobo
- Table 87 Representative Products Of Vector Labs
- List Of Figures
- Summary Figure: Markets For Labels And Probes By Application Area, 2003-2010 ($ Millions)
- Figure 1 Global Market By Materials For Probes In Immunoassays, 2003-2010 ($ Millions)
- Figure 2 Regional Share Of Markets For Probes In Immunoassays, 2005 (%)
- Figure 3 Global Market For Probes For In Vitro Diagnostics By Application Sectors, 2003-2010 ($ Millions)
- Figure 4 Global Market For Probes For In Vivo Diagnostics, 2003-2010 ($ Millions)
- Figure 5 Markets Of Fluorescent Compounds By Application Sectors, 2003-2010 ($ Millions)
- Figure 6 Markets For Radioactive Compounds By Application Sectors, 2003-2010 ($ Millions)
- Figure 7 Markets Of Chemiluminescent Compounds By Application Sectors, 2003-2010 ($ Millions)
- Figure 8 Markets For Enzymes And Their Substrates By Application Sectors, 2003-2010 ($ Millions)
- Figure 9 Markets For Gene Probes By Application Sectors, 2003- 2010 ($ Millions)
|
|
|
